GORDON CARL L
SEC insider (Form 3/4/5 filer). CIK 0001282930. Director & 10% Owner at ADARx Pharmaceuticals, Inc. (ADRX) and 7 other issuers. 36 reported Form 4/5 transactions since Sep 2024; latest on Sep 21, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies GORDON CARL L has filed insider reports for
- ADARx Pharmaceuticals, Inc. (ADRX): Director, 10% Owner
- Electra Therapeutics, Inc. (ETRA): Director
- BlossomHill Therapeutics, Inc. (BLSM): Director
- Scribe Therapeutics, Inc. (SCTX): Director
- Compass Therapeutics, Inc. (CMPX): Director
- Keros Therapeutics, Inc. (KROS): Director
- MBX Biosciences, Inc. (MBX): Director, 10% Owner
- Lomond Therapeutics Holdings, Inc. (NONE): Director
GORDON CARL L
CIK: 0001282930
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (8)
ADARx Pharmaceuticals, Inc.
Electra Therapeutics, Inc.
BlossomHill Therapeutics, Inc.
Scribe Therapeutics, Inc.
Compass Therapeutics, Inc.
Keros Therapeutics, Inc.
MBX Biosciences, Inc.
Lomond Therapeutics Holdings, Inc.
Discretionary Trading P&L
Holdings
Transaction History (36 total)
- Sep 21, 2026ETRA
Electra Therapeutics, Inc.
ConversionIndirect2M shares- - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
ConversionIndirect1.7M shares- - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
PurchaseIndirect1M shares at avg. $15.00$15.0M - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
ConversionIndirect758.3K shares- - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
PurchaseIndirect333.3K shares at avg. $15.00$5.0M - Sep 21, 2026ETRA
Electra Therapeutics, Inc.
ConversionIndirect1.1M shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
ConversionIndirect1M shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
ConversionIndirect1M shares- - Aug 10, 2026BLSM
BlossomHill Therapeutics, Inc.
PurchaseIndirect625K shares at avg. $16.00$10.0M - Aug 6, 2026BLSM
BlossomHill Therapeutics, Inc.
AwardDirectDirector Stock Option (Right to Buy)
23.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Conversion | 2,002,310 | - | $0 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Conversion | 1,703,314 | - | $0 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Purchase | 1,000,000 | $15.00 | $15,000,000 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Conversion | 758,279 | - | $0 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Purchase | 333,333 | $15.00 | $4,999,995 | Indirect |
| Sep 21, 2026 | ETRA Electra Therapeutics, Inc. | Conversion | 1,087,934 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion | 1,049,283 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Conversion | 1,039,996 | - | $0 | Indirect |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | Purchase | 625,000 | $16.00 | $10,000,000 | Indirect |
| Aug 6, 2026 | BLSM BlossomHill Therapeutics, Inc. | Award Director Stock Option (Right to Buy) | 23,904 | - | - | Direct |
1-10 of 36 transactions